Patch Biosciences used large-scale DNA synthesis and machine learning to design genetic medicines before Ginkgo acquired it in 2024.

Products & media

Patch Biosciences Platform

A machine-learning and functional-genomics platform for designing and screening genetic medicines against biological targets.

Cosigns

Elise FlynnData Lead, AI/ML at Biohub | Computational biologist working across genomics, AI/ML, and therapeutic research
“thanks to our incredible core mRNA team of @AlyssaKMorrow Ashley Thornal Emily Hoelzli Meimei Shan and @laserson from our time at Patch”
Source

Team

1 person across company lists

Founders

1 person

List
Uri Laserson

Jobs

See all jobs for Patch Biosciences here.

Company history

All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.

Leads

Participating Firms

Angels